Lysophosphatidic acid, which is a lipid growth factor and GPCR ligand, was found to stimulate aerobic glycolysis in cancer cells by inducing a pseudo-hypoxic response via upregulation of HIF1α levels (65); this response is involved in the transition of normal fibroblasts to a CAF phenotype. The gene discussed is HIF1A; the disease is cancer.